Intelligent Ultrasound Group PLC Capital Return Update
27 11월 2024 - 4:00PM
RNS Regulatory News
RNS Number : 7633N
Intelligent Ultrasound Group PLC
27 November 2024
Intelligent Ultrasound Group
plc
("Intelligent Ultrasound" or the "Group" or the
"Company")
Capital return
update
Intelligent Ultrasound Group plc
(AIM: IUG), the ultrasound simulation and education company,
announces that the Company has completed all the necessary
administrative steps (including court approval) for the reduction
of capital. This is now subject to registration at Companies House
before it becomes effective after which the Company will issue a
further announcement confirming registration. Once effective, the
Group will have the distributable reserves required to make a
material return of capital to shareholders.
The Group therefore expects to
confirm the plans for its Simulation Business and the exact amount
of money to be returned during December 2024.
In an update on the current year's
trading the Group confirms that, as at 22 November, Group unaudited
revenue was £8.1m (same period in 2023: £9.2m), with £7.4m (same
period in 2023: £8.4m) from continuing operations and £0.7m (same
period in 2023: £0.8m) from discontinued operations. Cash at bank
was
£39.6m.
For further information, please
contact:
Intelligent Ultrasound Group plc
|
www.intelligentultrasound.com
|
Stuart Gall, CEO
|
Tel: +44
(0)29 2075 6534
|
Helen Jones, CFO
|
|
|
|
Cavendish Capital Markets Limited
(Nominated advisor and broker)
|
|
Giles Balleny / Dan Hodkinson (Corporate Finance)
Nigel Birks (Life Sciences
Specialist Sales)
Dale Bellis (Sales)
|
Tel: +44
(0)20 7397 8900
|
|
|
Cardew Group - PR Advisors
|
Intelligentultrasound@cardewgroup.com
|
Allison Connolly
Emma Pascoe-Watson
Jessica Pilling
|
Tel: +44
(0)7587 453955
Tel: +44
(0)7774 620415
Tel: +44
(0)7918 584573
|
About Intelligent Ultrasound
Group
Intelligent Ultrasound (AIM:
IUG) is one of the world's leading ultrasound simulation and
education companies, specialising in real-time hi-fidelity virtual
reality simulation for the ultrasound training market.
The company's main
products are the ScanTrainer obstetrics and gynaecology
training simulator, the HeartWorks echocardiography
training simulator, the BodyWorks Eve Point of Care
and Emergency Medicine training simulator, the new BabyWorks
Neonate and Paediatric training simulator and NeedleTrainer, which teaches real-time ultrasound-guided
needling. To date over 1,800
simulators have been sold to over 800 medical
institutions around the world.
www.intelligentultrasound.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
MSCQKABNCBDDDDB
Intelligent Ultrasound (LSE:IUG)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Intelligent Ultrasound (LSE:IUG)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024